| scholarly article | Q13442814 |
| P2093 | author name string | Sukhminder Jit Singh Bajwa | |
| Ishwardip Singh Kwatra | |||
| P2860 | cites work | MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia | Q24290092 |
| Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 | ||
| Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin | Q24298747 | ||
| SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis | Q24299058 | ||
| Isolation and characterization of genomic and cDNA clones of human erythropoietin | Q24299960 | ||
| Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. | Q40858011 | ||
| Role of sugar chains in the in vitro biological activity of human erythropoietin produced in recombinant Chinese hamster ovary cells | Q41727703 | ||
| Core erythropoietin receptor signals for late erythroblast development | Q41996778 | ||
| Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors | Q42489065 | ||
| In vitro production of erythropoietin by mouse fetal liver | Q43603059 | ||
| Site of 1,25(OH)2 vitamin D3 synthesis in the kidney | Q43812165 | ||
| Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism | Q44020458 | ||
| Microheterogeneity of erythropoietin carbohydrate structure | Q46150335 | ||
| Nephrogenic diabetes insipidus: update of genetic and clinical aspects | Q47991177 | ||
| Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. | Q52026277 | ||
| DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. | Q54943458 | ||
| Identification of the renal erythropoietin-producing cells using transgenic mice | Q57378026 | ||
| Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin | Q68788619 | ||
| Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA | Q69222372 | ||
| Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin | Q70551126 | ||
| Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin | Q71570778 | ||
| Hypocalcemia, morbidity, and mortality in end-stage renal disease | Q71715176 | ||
| Control of renal function by intrarenal angiotensin II | Q71726250 | ||
| Erythropoietin receptors: their role beyond erythropoiesis | Q81666653 | ||
| Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene | Q93557533 | ||
| A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium | Q24308202 | ||
| Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. | Q24540520 | ||
| Cloning and expression of the human erythropoietin gene | Q24608978 | ||
| Cloning and expression of full-length cDNA encoding human vitamin D receptor | Q24650952 | ||
| Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis | Q28260847 | ||
| Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus | Q28280046 | ||
| Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells | Q28282130 | ||
| Concerted action of associated proteins in the regulation of TRPV5 and TRPV6 | Q28283921 | ||
| Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. | Q30176130 | ||
| Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation | Q30310896 | ||
| Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry | Q30404030 | ||
| Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation | Q33938586 | ||
| Sensing, signaling and sorting events in kidney epithelial cell physiology | Q33961141 | ||
| Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells | Q34311306 | ||
| Molecular biology of hereditary diabetes insipidus. | Q34442011 | ||
| Regulation of intrarenal angiotensin II in hypertension | Q34554367 | ||
| Proximal tubular handling of phosphate: A molecular perspective | Q34563763 | ||
| Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia | Q34581679 | ||
| TRPV5, the gateway to Ca2+ homeostasis | Q34600636 | ||
| Erythropoietin after a century of research: younger than ever | Q34606348 | ||
| Purification of human erythropoietin | Q34777478 | ||
| The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP. | Q35013346 | ||
| Intrarenal angiotensin II and hypertension | Q35087015 | ||
| Expression cloning of the murine erythropoietin receptor | Q35416452 | ||
| Turning cells red: signal transduction mediated by erythropoietin | Q36064203 | ||
| Disorders of body water homeostasis in critical illness | Q36663968 | ||
| New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. | Q36905432 | ||
| Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption | Q37145917 | ||
| Aquaporin-2 in the "-omics" era | Q37200830 | ||
| Aquaporins in kidney pathophysiology | Q37681294 | ||
| Human prorenin | Q37687876 | ||
| Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine | Q39918477 | ||
| Vitamin D: recent advances | Q40137018 | ||
| Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors | Q40488393 | ||
| Molecular biology of the renin-angiotensin system | Q40854596 | ||
| P433 | issue | 2 | |
| P921 | main subject | molecular genetics | Q210506 |
| P304 | page(s) | 158-163 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Indian Journal of Endocrinology and Metabolism | Q15816442 |
| P1476 | title | Reno-endocrinal disorders: A basic understanding of the molecular genetics | |
| P478 | volume | 16 |
| Q38115310 | Anesthetic management of primary hyperparathyroidism: A role rarely noticed and appreciated so far. |
| Q38255805 | Endocrine anesthesia: A rapidly evolving anesthesia specialty |
| Q36426215 | Peri-operative renal protection: The strategies revisited |
| Q37239003 | Pharmaco-genomics and anaesthesia: Mysteries, correlations and facts |
| Q34196827 | Predictors of acute kidney injury in geriatric patients undergoing total knee replacement surgery |
Search more.